Table 4.
PROPORTION (95% CI) |
||||
---|---|---|---|---|
METABOLIC ABNORMALITIES | EAST ASIAN DESCENT (N = 130) | SOUTH ASIAN DESCENT (N = 113) | EUROPEAN DESCENT (N = 111) | P VALUE* |
Hypertension (BP > 130/85 mm Hg) | 20.0 (13.1–26.9) | 20.4 (13.0–27.8) | 28.8 (20.4–37.2) | > .05 |
Elevated TG level (TG >1.7 mmol/L) | 26.9 (19.3–34.5) | 25.7 (17.6–33.8) | 20.7 (13.2–28.2) | > .05 |
Impaired fasting glucose (> 5.6 mmol/L) | 10.0 (4.8–15.2) | 13.3 (7.0–19.6) | 12.6 (6.4–18.8) | > .05 |
HOMA-IR | 23.8 (16.5–31.1) | 25.7 (17.6–33.8) | 24.3 (16.3–32.3) | > .05 |
MetS by WHO criteria18 | 17.7 (11.1–24.3) | 17.7 (10.7–24.7) | 18.9 (11.6–26.2) | > .05 |
MetS by ATP III criteria19 | 19.2 (12.4–25.9)a | 26.5 (18.4–34.6)ab | 36.0 (27.1–44.9)b | < .01 |
MetS by IDF criteria20 | 6.5 (2.3–10.7)a | 17.7 (10.7–24.7)b | 15.3 (8.6–22.0)b | < .05 |
ATP—Adult Treatment Panel, BP—blood pressure, CI—confidence interval, HOMA-IR—homeostatic model assessment of insulin resistance, IDF—International Diabetes Federation, MetS—metabolic syndrome, TG—triglyceride, WHO—World Health Organization.
Comparison among 3 ethnic groups by χ2 test; percentages with different letters are significantly different by pair-wise χ2 tests with P values less than .025 to account for family-wise error rate.